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Background: Mutation spectra of the CFTR gene vary between populations. 
Knowledge of these mutation spectra is needed for diagnostic purposes, for 
counselling in CF families and for screening, either neonatal to improve prognosis, 
or preconceptional and prenatal to provide for reproductive options. There is only 
limited knowledge about he mutation spectra in migrant populations in Europe. 
Aims: To determine the identity and frequency of mutations found in Turkish and 
North-African CF patients and to determine the test-sensitivity of common CF-gene 
mutation panels when offering carrier screening to Mediterranean people. 
Methods: In a survey among 373 European CF-centres, we asked which mutations 
have been found among Turkish and North African CF patients. 
Results: Fifty mutations had been found on 75.2% (95% CI: 70.4 80.0%) of CFTR 
alleles of patients (n 156) originating from Turkey or North Africa. The mean 
sensitivity of common CF-gene mutation panels to detect hese mutations was 
50.6% (95% CI: 45.0 56.2%), and differed significantly between Turkish and North- 
African people: 41.7% (95% CI: 34.7 48.6%) versus 66.4% (95% CI: 57.7 75.2%). 
A sensitivity of 63.6% (95%CI: 58.2 69.0) can be achieved by expanding the 
mutation panels with these Mediterranean mutations. 
Conclusion: A low test-sensitivity of common CF-gene mutation panels for carrier 
screening of Mediterranean people was observed. This raises questions on whether 
and how to implement CF-carrier screening in a multi-ethnic society. 
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The aim was to describe a variety of clinical phenotype of L138ins mutation 
(consequence insertion of leucine at 138 in Exon 4) in Russian CF patients. 
Methods: molecular genetic identification (sequence of exon 4), evaluation of 
clinical status, sweat est values (ST), chest X-ray, sputum bacterial colonisation. 
Results: 1997Q005 we found 5 subjects compound heterozygous for L138ins 
mutation and other CF mutations. The frequency of L138ins mutation is 0.8% of all 
mutant alleles of CFTR gene in Russia. Median (M) age at date of diagnosis of CF 
8.6 years [0.2 16 yr]. 2 patients (F508del/L138ins) were diagnosed before 5 months. 
1 (2184insA/L138ins) after 10 years and 2 (CFTRdele2,3(21kb)/L138ins) after 
16 years. M age at 01.2006 was 9.6±5.64yr [16;3.2]. M level of ST was 90.5 mmol/1 
[64.8;119.5]. M Wt%/Ht% 92.5% [85;110%] before the treatment. 3 patients 
have mainly bronchopulmonary manifestation of the disease: cough from 1 1.5 
months, bronchopulmonary exacerbations 2 3 times in year, requiring antibiotics 
tre atment. 2 of these patients (2184insA/L 138ins and CFTRdele2,3 (21 kb)/L 138ins) 
have athelectasis of median lobe, they also have atopy (bronchial asthma, allergic 
bronchopulmonary spergillosis,recurrent sinusitis and drug intolerance). 3 patients 
are on a low dose of pancreatic enzymes, and 1 (2184insA/L138ins) has a normal 
level of faecal elastasel 507.1 gg/1. 4 patients have biliary dyskinesia (2 of them 
have cholelithiasis). All patients have chronic colonization of St. aureus, 2 
Ps.aeruginosa, 1 Candida sp. 
Conclusion: It should be proposed that L138ins mutant CFTR protein conserves 
a residual activity. This fact may impact on the better prognosis of CF patients 
with this mutation in CF genotype (at least, in heterozygous status of such severe 
mutations as F508del, CFTRdele2,3(21kb), 2184insA). 
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Aims: To describe a case of atypical cystic fibrosis in a Chinese male and review 
a rare CFTR mutation. 
Methods: A 43 year-old Chinese male never smoker presented with his wife to the 
Infertility Clinic. He had never fathered any children. He was found to have apparent 
congenital bilateral absence of the vas deferens (CBAVD) with severe oligospermia 
(sperm concentration 0.6 million, volume 3.3 ml, morphology 12% normal). He was 
otherwise well with no past medical history. He had no respiratory symptoms. There 
was no family history of cystic fibrosis or any other respiratory disorder but there 
was a family history of thalassemia minor. His chest radiograph and pulmonary 
function tests were all normal. Oxygen saturation on room air was normal at 98%. 
His sweat chloride test was normal at 32 mmol/L. 
Results: Genetics testing revealed homozygosity for an exon 11 transition mutation 
changing A to G at position 1798. This yielded an amino acid substitiution at 
position 556 with Valine replacing the normal Isoleucine residue. 
Discussion: This is the first reported case of a homozygosity for the p.I556V 
mutation. This mutation has been reported in 2 other patients in a heterozygous 
state. Ghanem (1992) reported a45 year-old fertile male with moderate pulmonary 
symptoms and a positive sweat chloride and a I556L/R31C mutation. While CFTR 
gene mutations are not common in Asians, there is growing evidence of cystic 
fibrosis in this population. However, it is felt that the mutation spectrum of 
CFTR in CBAVD may be different han the Caucasian population (Wong LJ et 
al, Hum Reprod, 2005). It is important o consider atypical cystic fibrosis in 
men presenting with infertility and evaluate for alternative mutations in the non- 
Caucasian population. 
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The molecular diagnosis of Cystic Fibrosis is based on the genotype characterization 
by the CFTR gene mutation screening. More than 1400 mutations related with 
CF disease have been described. Substantial variation in the many aspects of CF 
phenotype among individuals bearing the same genotypes emphasizes the role 
of genetic background and environment. The different clinical expressions could 
be related to the presence of some complex alleles, since many CF mutations, 
associated to the most severe clinical features, have a wide expression incidence 
depending on the presence of an additional mild mutation in the same subject. The 
aim of this study was to analyze the frequency of complex alleles in the cohort of 
27 classic CF patients followed at the CF Centre of Lombardy Region. 
Molecular analysis of the coding regions, performed by DHPLC and 
automatic sequencing, allowed us to identify the follow complex alle- 
les G542X/L 1069R-L967S;DeltaF508/2183AA ~ G-V 1153E;DeltaF508/W361R- 
R334L; DeltaF508/Y1032C-L137P; DeltaF508/S997F-R1438W, DeltaF508-A234D- 
I1027% The inheritance of these complex alleles was confirmed by family studies 
involving parents, and, in some cases, grandparents. 
Probably L1069R-L967S; Vl153E; W361R-R334L, Y1032C-L137R S997F- 
R1438W, A234D-I1027T in isolation should be considered as neutral variants but 
might significantly impair CFTR function when inherited in cis with another CFTR 
mutation. These data document the contribution of complex alleles to the wide 
phenotypic variability of CE 
Only functional expression studies of such complex alleles could elucidate their 
role in the pathogenesis of disease. 
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